Global S&T Development Trend Analysis Platform of Resources and Environment
Imperial experts engage world leaders as G7 begins | |
admin | |
2021-06-11 | |
发布年 | 2021 |
语种 | 英语 |
国家 | 英国 |
领域 | 资源环境 |
正文(英文) | The Imperial community is playing a pivotal role in informing and influencing the G7 Summit. The UK has taken on the Presidency of the G7 group of nations in 2021, with the G7 Summit set to take place in Carbis Bay, Cornwall on 11-13 June 2021. Imperial researchers are helping G7 leaders make better informed decisions on health resilience, sustainable growth, disease and economic modelling, antimicrobial resistance, and artificial intelligence during the UK’s presidency of the group of wealthy democracies. Reform for Resilience CommissionImperial is one of the advisers and partners to the Reform for Resilience Commission, an advisory body of experts and policymakers set up to advise on how we can improve economic and health resilience following COVID-19. Imperial’s Professor Lord Darzi, Paul Hamlyn Chair of Surgery and Co-Director of the Institute of Global Health Innovation, is one of the commissioners. Last week, the Commission released its interim report on Healthy Growth, which sets out recommendations for the G7, key lessons from the COVID-19 pandemic and a vision for building health and economic resilience. The interim report urges G7 leaders to address the following challenges:
We have drawn on our expertise right across the College to inform these important discussions at the G7 and beyond. Professor Deborah Ashby Imperial College London Led by Professor Francisco Veloso, Dean of the Business School and Professor Deborah Ashby, Director of the School of Public Health, a team of Imperial academics submitted evidence to the commission, supported by The Forum, Imperial’s policy engagement programme. Key recommendations from Imperial’s submission were cited in the report, including:
Professor Deborah Ashby said: “Imperial researchers, especially in the Faculty of Medicine, have played a major role in addressing the challenges presented by COVID-19 pandemic as it has evolved. Attention now also needs to focus on the broader global implications and resilience over the longer term, so we have drawn on our expertise right across the College to inform these important discussions at the G7 and beyond.” The final report will be published in November alongside a Global Resilience Summit. Tackling antimicrobial resistanceThe silent pandemic of antimicrobial resistance (AMR) is on the agenda of the G7 Summit. In the Summit the G7 Health Ministers committed to take strategic actions on AMR, alongside global health security, clinical trials and digital health. Imperial academics are part of a group of experts led by Professor Alison Holmes working on an upcoming review of current evidence and an interdisciplinary consensus on key priorities for research on optimising antimicrobial use in human populations, to coincide with and feed into the G7 Summit. A major driver of AMR and poor clinical outcomes is suboptimal antimicrobial use, with current research inequitably focused on the need for new drug development. To achieve antimicrobial security, the strategic research priorities identified the critical need to balance AMR research efforts between the development of new agents and strategies to preserve the efficacy and maximise effectiveness of existing agents. This work identifies research priorities for optimising antimicrobial use and outline actions and strategies to contribute to equitable global health security. “The global research agenda must also focus on preserving and maximising the effectiveness of our existing antimicrobials.” Professor Alison Holmes Imperial College London Alongside this paper, this multidisciplinary team of experts led by Imperial with their global partners have put together a proposed roadmap for healthcare professionals, policymakers and advocacy groups to address identified research priorities for optimising antimicrobial use in humans. It recommends that in order to address gaps in AMR and achieve antimicrobial security, research should focus on building capacity for conducting equitable research across four distinct research themes: policy and strategic planning, medicines management and prescribing systems, technological innovation, and context, culture and behavioural research. Professor Alison Holmes said: "There has been major research investment in the development of new antimicrobials to treat drug resistant infection. However, whilst the world waits for new agents, the global research agenda must also focus on preserving and maximising the effectiveness of our existing antimicrobials." Esmita Charani, Senior Lead Research Pharmacist, Department of Infectious Disease, and one of the authors, said: "Antimicrobial Resistance is a global threat that can only be addressed through collaboration and partnerships spanning different healthcare economies, sectors, and populations. "Working with expert colleagues around the world, including patient and public advocates, we have identified the key research priorities that need to be addressed if we are to optimise the use of existing and emerging antibiotics. The next steps are to act on this work and respond to these identified research needs through building on our existing global research partnerships and collaboration across different health economies and populations.'' The next steps are to act on this work and respond to these identified research needs through building on our existing global research partnerships and collaboration across different health economies and populations. Dr Esmita Charani Imperial College London Imperial is also contributing its expertise via an upcoming paper on innovation and technology to support optimised antimicrobial use and precision prescribing. It will review state-of-the-art technologies under development that have the potential to address current barriers and support wider implementation of precision antimicrobial dosing. This includes Imperial based research from the Centre for Antimicrobial Optimisation (CAMO) on biosensor-based, real-time therapeutic drug monitoring, closed-loop control systems and artificial intelligence-driven decision support tools. Dr Timothy Miles Rawson, Honorary Clinical Research Fellow in the Department of Infectious Disease said: “Optimising the use of antimicrobials is important to ensure the best outcomes for our patients with infection, whilst minimising the development of drug-resistance. Our review explores the state-of-the-art in this field, much of which has been pioneered by collaboration between departments at Imperial College London working within the Centre for Antimicrobial Optimisation.” U7+ AllianceThe U7+ Alliance of universities, which includes Imperial, has called on the G7 to recognise the key role that universities play as primary global actors and wishes to highlight priority areas in terms of opportunities to collaborate with G7 leaders to actively take responsibility for and foster intergenerational dialogue on issues of importance to this year’s multilateral agenda:
The U7+ Alliance spans six continents and represents all of the G7 nations as well as 10 other nations. It is the first alliance of university presidents aimed at structuring and advancing their role as global actors across the multilateral agenda. |
URL | 查看原文 |
来源平台 | Imperial College London |
文献类型 | 新闻 |
条目标识符 | http://119.78.100.173/C666/handle/2XK7JSWQ/329695 |
专题 | 资源环境科学 |
推荐引用方式 GB/T 7714 | admin. Imperial experts engage world leaders as G7 begins. 2021. |
条目包含的文件 | 条目无相关文件。 |
个性服务 |
推荐该条目 |
保存到收藏夹 |
查看访问统计 |
导出为Endnote文件 |
谷歌学术 |
谷歌学术中相似的文章 |
[admin]的文章 |
百度学术 |
百度学术中相似的文章 |
[admin]的文章 |
必应学术 |
必应学术中相似的文章 |
[admin]的文章 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论